Regulatory mechanism of matrix metalloproteinase activity.
Regulatory mechanism of matrix metalloproteinase activity.
批准号:
04680169
负责人:
MIYAZAKI Kaoru
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Matrix metalloproteinases (MMPs) are involved in various physiological and pathological conditions including arthritis and tumor metastasis. The activity of MMPs are regulated by three mechanisms : regulation of synthesis, activation of their latent proenzymes, and regulation of active enzymes by natural inhibitors. Proenzymes of most MMPs are known to be activated by some serine proteinases, whereas only the activating enzymes of pro-gelatinase A remain unknown. The present study aimed to clarify the natural activators of pro-gelatinase A.Pro-gelatinase A was purified in TIMP-2 bound and -free forms from conditioned medium of T98G human glioblastoma cell line. The TIMP-2-free pro-gelatinase A of 64 kDa (apparent molecular size under nonreducing conditions) was rapidly activated to the 57-kDa and then the 41-kDa mature forms by treatment with p-aminophenylmercuric acetate (APMA). When the TIMP-2-free form was incubated with stromelysin, a member of MMP family, its gelatinolytic activity increased to about 70% of the activity obtained by APMA activation, forming the 41-kDa form. The treatment of the TIMP-2-bound pro-gelatinase A with stromelysin also increased its gelatinolytic activity but hardly produced any mature forms. Analysis of interaction of the TIMP-2-bound proenzyme and stromelysin demonstrated that stromelysin bound to the TIMP-2 molecule in the TIMP-2/pro-gelatinase A complex, forming a tertiary protein complex with a significant gelatinolytic activity. These results suggest that stromelysin may function as a natural activator of pro-gelatinase A under some conditions.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Miyazaki,K.,et al.: "Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases(TIMP)type 2 and a low molecular weight TIMP-like protein." J.Biol.Chem.268. 14387-14393 (1993)
Miyazaki, K. 等人:“双链形式的 2 型金属蛋白酶组织抑制剂 (TIMP) 和低分子量 TIMP 样蛋白的纯化和表征。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kato, Y., Nakayama, Y., Umeda, M., and Miyazaki, K.: "Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines." J.Biol.Chem.267. 11424-11430 (1992)
Kato, Y.、Nakayama, Y.、Umeda, M. 和 Miyazaki, K.:“在小鼠转移性黑色素瘤细胞系中通过酸性培养条件诱导 103-kDa 明胶酶/IV 型胶原酶。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Nakashima,et al.: "Structure of Aα chains of human fibrinogen fraction II." Blood Coagul.Fibrin.3. 361-370 (1992)
A.Nakashima 等人:“人纤维蛋白原组分 II 的 Aα 链结构。纤维蛋白 361-370”(1992 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
宮崎香: "実験医学(羊土社)11巻" アルツハイマー病アミロイド蛋白質前駆体のプロセッシング酵素とインヒビタ, 74-76 (1993)
宫崎薰:“实验医学(Yodosha)第11卷”阿尔茨海默病淀粉样蛋白前体加工酶和抑制剂,74-76(1993)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyazaki, K., Umenishi, F., Funahashi, K., Koshikawa, N., Yasumitsu, H., and Umeda, M.: "Activation of TIMP-2/progelatinase A complex by stromelysin." Biochem.Biophys.Res.Commun.185. 852-859 (1992)
Miyazaki, K.、Umenishi, F.、Funahashi, K.、Koshikawa, N.、Yasumitsu, H. 和 Umeda, M.:“溶基质素激活 TIMP-2/原明胶酶 A 复合物。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Interaction of cancer cells with basement membrane proteins
-
批准号:17014077
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$29.95万
-
财政年份:2005
-
负责人:MIYAZAKI Kaoru
-
依托单位:
Application of a new cell-adhesive and cell-migatory molecule, laminin-5B, to regenerative medicine
-
批准号:17300157
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2005
-
负责人:MIYAZAKI Kaoru
-
依托单位:
Structure and Function of Laminin-5, a Cell Adhesion Protein of Basement Membrane
-
批准号:11490030
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.33万
-
财政年份:1999
-
负责人:MIYAZAKI Kaoru
-
依托单位:
Structures and functions of growth inhibitors secreted from rat liver cell lines
-
批准号:63580123
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1988
-
负责人:MIYAZAKI Kaoru
-
依托单位:
Molecular Diversity and Physiological Roles of Growth Inhibitors
-
批准号:63304060
-
项目类别:Grant-in-Aid for Co-operative Research (A)
-
资助金额:$8.96万
-
财政年份:1988
-
负责人:MIYAZAKI Kaoru
-
依托单位:
Properties and Physiological Roles of Cell Growth Inhibitors Present in Blood
-
批准号:60480500
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1985
-
负责人:MIYAZAKI Kaoru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
-
批准号:82371223
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:闻大翔
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
-
批准号:82372089
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李万万
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
-
批准号:82372724
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:何竑超
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
EGFR通过激活β-catenin重塑肿瘤微环境代谢调控肿瘤免疫逃逸的分子机制研究
-
批准号:32100574
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邵飞
-
依托单位:
脯氨酸羟化酶EglN1转位到线粒体介导乳腺癌细胞适应缺氧应激的机制研究
-
批准号:32100570
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:闫朝君
-
依托单位: